Brief: Resverlogix - Expect To File Its Interim Financial Statements And Related MD&A For Three Months Ended July 31, 2020 On/About October 5
Sept 25 (Reuters) - Resverlogix Corp RVX.TO :
* RESVERLOGIX - EXPECT TO FILE ITS INTERIM FINANCIAL
STATEMENTS
AND RELATED MD&A FOR THREE MONTHS ENDED JULY 31, 2020 ON/ABOUT
OCTOBER 5
Source text for Eikon: ID:nGNX21N7xy
Further company coverage: RVX.TO
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Resverlogix
See all newsBrief: Resverlogix Confirms Focus On Treatment Of Post Covid-19 Conditions
Brief: Resverlogix Announces New Research Findings Highlighting Safety Of BD2-Selective BET Inhibitors
Brief: Resverlogix Announces Type C Meeting With FDA For Coral, A Phase 3 High-Risk Covid-19 Outpatient Study
Brief: Resverlogix Expands Phase 2B Clinical Trial For Covid-19 Treatment With First Site In Brazil And Second In Canada
Brief: Resverlogix Announces Commencement Of Patient Enrollment And Dosing In A Phase 2B Trial For COVID-19 Treatment